For research use only. Not for therapeutic Use.
Atorvastatin-Amlodipine Adduct (CAT: C000053) is an innovative amlodipine/atorvastatin amide prodrug, designed to combine the therapeutic benefits of amlodipine, a calcium channel blocker for hypertension and angina, with atorvastatin, a statin medication for lowering cholesterol. This prodrug offers a convenient treatment option for patients with both conditions, enhancing medication adherence and therapeutic effectiveness by releasing the active ingredients in a controlled manner.
| Catalog Number | C000053 |
| CAS Number | 425408-16-8 |
| Synonyms | 3-Ethyl 5-Methyl 4-(2-Chlorophenyl)-2-[[2-[[(3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3,5-dihydroxy-1-oxoheptyl]amino]ethoxy]methyl]-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate |
| Molecular Formula | C₅₃H₅₈ClFN₄O₉ |
| Purity | ≥95% |
| Solubility | DMSO (Slightly, Sonicated), Methanol (Slightly) |
| Appearance | White to Off-White Solid |
| Storage | -20°C, Inert atmosphere |
| Reference | Crook, Robert J., et al.: Eur. Pat. Appl., EP 1205477 A1 20020515 (2002) |
